Intensive lifestyle changes may affect the progression of prostate cancer
- PMID: 16094059
- DOI: 10.1097/01.ju.0000169487.49018.73
Intensive lifestyle changes may affect the progression of prostate cancer
Abstract
Purpose: Men with prostate cancer are often advised to make changes in diet and lifestyle, although the impact of these changes has not been well documented. Therefore, we evaluated the effects of comprehensive lifestyle changes on prostate specific antigen (PSA), treatment trends and serum stimulated LNCaP cell growth in men with early, biopsy proven prostate cancer after 1 year.
Materials and methods: Patient recruitment was limited to men who had chosen not to undergo any conventional treatment, which provided an unusual opportunity to have a nonintervention randomized control group to avoid the confounding effects of interventions such as radiation, surgery or androgen deprivation therapy. A total of 93 volunteers with serum PSA 4 to 10 ng/ml and cancer Gleason scores less than 7 were randomly assigned to an experimental group that was asked to make comprehensive lifestyle changes or to a usual care control group.
Results: None of the experimental group patients but 6 control patients underwent conventional treatment due to an increase in PSA and/or progression of disease on magnetic resonance imaging. PSA decreased 4% in the experimental group but increased 6% in the control group (p = 0.016). The growth of LNCaP prostate cancer cells (American Type Culture Collection, Manassas, Virginia) was inhibited almost 8 times more by serum from the experimental than from the control group (70% vs 9%, p <0.001). Changes in serum PSA and also in LNCaP cell growth were significantly associated with the degree of change in diet and lifestyle.
Conclusions: Intensive lifestyle changes may affect the progression of early, low grade prostate cancer in men. Further studies and longer term followup are warranted.
Similar articles
-
Clinical events in prostate cancer lifestyle trial: results from two years of follow-up.Urology. 2008 Dec;72(6):1319-23. doi: 10.1016/j.urology.2008.04.050. Epub 2008 Jul 7. Urology. 2008. PMID: 18602144 Clinical Trial.
-
Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.Clin Cancer Res. 2006 Jul 1;12(13):4018-26. doi: 10.1158/1078-0432.CCR-05-2290. Clin Cancer Res. 2006. PMID: 16818701 Clinical Trial.
-
Prevalence of prostate specific antigen testing for prostate cancer in elderly men.J Urol. 2006 Jun;175(6):2078-82. doi: 10.1016/S0022-5347(06)00266-7. J Urol. 2006. PMID: 16697807
-
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.BJU Int. 2007 Jan;99 Suppl 1:13-6; discussion 17-8. doi: 10.1111/j.1464-410X.2007.06594.x. BJU Int. 2007. PMID: 17229162 Review.
-
Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention?Urol Clin North Am. 2004 May;31(2):301-11. doi: 10.1016/j.ucl.2004.03.007. Urol Clin North Am. 2004. PMID: 15123409 Review.
Cited by
-
Metabolomics in cancer research and emerging applications in clinical oncology.CA Cancer J Clin. 2021 Jul;71(4):333-358. doi: 10.3322/caac.21670. Epub 2021 May 13. CA Cancer J Clin. 2021. PMID: 33982817 Free PMC article. Review.
-
Plasma genistein and risk of prostate cancer in Chinese population.Int Urol Nephrol. 2015 Jun;47(6):965-70. doi: 10.1007/s11255-015-0981-5. Epub 2015 May 14. Int Urol Nephrol. 2015. PMID: 25971353 Free PMC article.
-
An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis.J Cancer Surviv. 2010 Jun;4(2):87-100. doi: 10.1007/s11764-009-0110-5. Epub 2010 Jan 6. J Cancer Surviv. 2010. PMID: 20052559 Review.
-
Uric Acid and Plant-Based Nutrition.Nutrients. 2019 Jul 26;11(8):1736. doi: 10.3390/nu11081736. Nutrients. 2019. PMID: 31357560 Free PMC article. Review.
-
Reframing How Physical Activity Reduces The Incidence of Clinically-Diagnosed Cancers: Appraising Exercise-Induced Immuno-Modulation As An Integral Mechanism.Front Oncol. 2022 Mar 14;12:788113. doi: 10.3389/fonc.2022.788113. eCollection 2022. Front Oncol. 2022. PMID: 35359426 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
